Главная
Study mode:
on
1
Intro
2
Sarcoma subtypes
3
Sloan Kettering data
4
Leiomyosarcoma prevalence
5
Survival
6
Grade
7
Size
8
Prognostic Model
9
Data Sets
10
nomagrams
11
sitespecific nomogram
12
data set
13
how it works
14
Surgery
15
Malignant Potential
16
Imaging
17
Retroperitoneal disease
18
Core biopsy
19
Examples
20
Importance of Diagnosis
21
Preoperative Planning
22
Vascular Graph
23
Multidisciplinary Team
24
Imaging review
25
Multidisciplinary sarcoma center
26
Clinical trials
27
How does the drug work
28
Surgical orthotopic implantation
29
Treatment of mouse models
30
Summary data
31
Lowgradesarcoma
32
Treatment of highgradesarcoma
33
Is it feasible
34
Misdiagnosis
35
Sarcoma error rate
36
Environmental factors
37
Fresh tissue
38
Laparoscopy
Description:
Explore the history and advancements in Leiomyosarcoma treatment at UCLA in this informative lecture by Dr. Fritz C. Eilber, Director of the UCLA Sarcoma Clinical/Translational Research Program. Delve into various sarcoma subtypes, survival rates, and prognostic models using data from Sloan Kettering. Gain insights into the importance of accurate diagnosis, preoperative planning, and the role of multidisciplinary teams in sarcoma treatment. Learn about cutting-edge research, including surgical orthotopic implantation and mouse model treatments. Discover the challenges of misdiagnosis, environmental factors, and the significance of fresh tissue samples. Understand the complexities of treating low-grade and high-grade sarcomas, and the potential of personalized therapy approaches in improving patient outcomes.

Leiomyosarcoma: Personalized Sarcoma Therapy - Fritz C. Eilber, MD | UCLA Cancer Care

University of California, Los Angeles
Add to list